Genic Co., Ltd. (KOSDAQ:123330)
South Korea
· Delayed Price · Currency is KRW 22,900
+4,000 (21.16%)
At close: Mar 6, 2026
Genic Revenue
Genic had revenue of 23.56B KRW in the quarter ending September 30, 2025, with 55.67% growth. This brings the company's revenue in the last twelve months to 85.47B, up 133.10% year-over-year. In the year 2024, Genic had annual revenue of 49.91B with 77.80% growth.
Revenue (ttm)
85.47B
Revenue Growth
+133.10%
P/S Ratio
2.05
Revenue / Employee
263.80M
Employees
324
Market Cap
174.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 49.91B | 21.84B | 77.80% |
| Dec 31, 2023 | 28.07B | -3.38B | -10.74% |
| Dec 31, 2022 | 31.45B | -6.96B | -18.12% |
| Dec 31, 2021 | 38.41B | -3.72B | -8.84% |
| Dec 31, 2020 | 42.13B | -1.02B | -2.36% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Manyo Factory | 118.72B |
| CLIO Cosmetics Co.,Ltd | 326.53B |
| Englewood Lab | 204.62B |
| Raphas | 32.16B |
| C&C International | 271.51B |
| Icure Pharmaceutical Incorporation | 93.22B |
| Coreana Cosmetics | 76.53B |
| SR biotek | 1.62B |